PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsProbenecid
Probenecid
Orlynvah, Polycillin-prb, Probalan, Probampacin, Probenecid (probenecid) is a small molecule pharmaceutical. Probenecid was first approved as Principen w/ probenecid on 1982-01-01. It is used to treat gonorrhea, gout, and neurosyphilis in the USA. The pharmaceutical is active against solute carrier family 22 member 6. In addition, it is known to target solute carrier organic anion transporter family member 1C1 and transient receptor potential cation channel subfamily V member 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
musculoskeletal diseasesD009140
nervous system diseasesD009422
urogenital diseasesD000091642
hereditary congenital and neonatal diseases and abnormalitiesD009358
nutritional and metabolic diseasesD009750
Trade Name
FDA
EMA
Probalan, Probenecid (discontinued: Benemid, Probenecid)
Combinations
Col-probenecid, Orlynvah, Probenecid colchicine (discontinued: Colbenemid, Polycillin-prb, Principen w/ probenecid, Probampacin, Proben-c, Probenecid colchicine, Probenecid w/ colchicine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Probenecid
Tradename
Company
Number
Date
Products
BENEMIDMerck & CoN-007898 DISCN1982-01-01
1 products, RLD
Hide discontinued
Colchicine
+
Probenecid
Tradename
Company
Number
Date
Products
COLBENEMIDMerck & CoN-012383 DISCN1982-01-01
1 products, RLD
Hide discontinued
Ampicillin
+
Ampicillin trihydrate
+
Probenecid
Tradename
Company
Number
Date
Products
PRINCIPEN W/ PROBENECIDBristol Myers SquibbN-050488 DISCN1982-01-01
1 products
POLYCILLIN-PRBBristol Myers SquibbN-050457 DISCN1982-01-01
1 products
Hide discontinued
Probenecid
+
Sulopenem etzadroxil
Tradename
Company
Number
Date
Products
ORLYNVAHIterum TherapeuticsN-213972 RX2024-10-25
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
orlynvahNew Drug Application2025-03-20
probalance hand sanitizer advancedOTC monograph not final2020-05-20
probenecidANDA2026-01-28
probenecid and colchicineANDA2026-01-27
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
gonorrheaDOID_7551D006069A54
neurosyphilisEFO_0007339D009494A50.40
goutEFO_0004274D006073M10
biliary liver cirrhosis—D008105K74.3
amyloidosisEFO_1001875D000686E85
familial mediterranean fever—D010505M04.1
respiratory tract infections—D012141J06.9
urinary tract infectionsEFO_0003103D014552N39.0
pneumococcal infectionsEFO_0000772D011008J13
infectious pregnancy complications—D011251—
Show 16 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
M: Musculo-skeletal system drugs
— M04: Antigout preparations
— M04A: Antigout preparations
— M04AB: Preparations increasing uric acid excretion
— M04AB01: Probenecid
HCPCS
No data
Clinical
Clinical Trials
67 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Urinary tract infectionsD014552EFO_0003103N39.01—3—15
InfectionsD007239EFO_0000544—1—2——3
Intraabdominal infectionsD059413——1—1——2
Communicable diseasesD003141——1—1——2
CystitisD003556EFO_1000025N30——1——1
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PyelonephritisD011704EFO_1001141N10-N161———12
PharmacokineticsD010599——1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameProbenecid
INNprobenecid
Description
Probenecid is a sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups. It has a role as a uricosuric drug. It is a sulfonamide and a member of benzoic acids.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1
Identifiers
PDB—
CAS-ID57-66-9
RxCUI—
ChEMBL IDCHEMBL897
ChEBI ID8426
PubChem CID4911
DrugBankDB01032
UNII IDPO572Z7917 (ChemIDplus, GSRS)
Target
Agency Approved
SLC22A6
SLC22A6
Organism
Homo sapiens
Gene name
SLC22A6
Gene synonyms
OAT1, PAHT
NCBI Gene ID
9356
Protein name
solute carrier family 22 member 6
Protein synonyms
hOAT1, hPAHT, hROAT1, Organic anion transporter 1, PAH transporter, para-aminohippurate transporter, Renal organic anion transporter 1, solute carrier family 22 (organic anion transporter), member 6
Uniprot ID
Q9UEQ8
Mouse ortholog
Slc22a6 (18399)
solute carrier family 22 member 6 (Q8VC69)
Alternate
SLCO1C1
SLCO1C1
TRPV2
TRPV2
Organism
Homo sapiens
Gene name
SLCO1C1
Gene synonyms
OATP14, OATP1C1, OATPF, SLC21A14
NCBI Gene ID
53919
Protein name
solute carrier organic anion transporter family member 1C1
Protein synonyms
OAT-RP-5, OATP-14, OATP-F, OATP-RP5, OATP1C1, Organic anion transporter 1C1, Organic anion transporter F, Organic anion transporter polypeptide-related protein 5, organic anion transporting polypeptide 14, Organic anion-transporting polypeptide 14, solute carrier family 21 (organic anion transporter), member 14, Solute carrier family 21 member 14, Thyroxine transporter
Uniprot ID
Q9NYB5
Mouse ortholog
Slco1c1 (58807)
solute carrier organic anion transporter family member 1C1 (Q9ERB5)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Probenecid
+
Colchicine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Probenecid
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 11,789 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
280 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use